Cimetropium bromide
CAS: 51598-60-8
Ref. 3D-FC152009
25mg | 136,00 € | ||
50mg | 195,00 € | ||
100mg | 325,00 € | ||
250mg | 589,00 € | ||
500mg | 865,00 € |
Información del producto
- (1S,2R,4S,5S)-9-(cyclopropylmethyl)-7-{[(2R)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane bromide
- (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-9-(Cyclopropylmethyl)-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-3-oxa-9-azoniatricyclo(3.3.1.0(sup 2,4))nonane bromide
- 3-Oxa-9-azatricyclo[3.3.1.0<sup>2,4</sup>]nonane, 3-oxa-9-azoniatricyclo[3.3.1.0<sup>2,4</sup>]nonane deriv.
- 3-Oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane, 9-(cyclopropylmethyl)-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, bromide, (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-
- 3-Oxa-9-azoniatricyclo[3.3.1.0<sup>2,4</sup>]nonane, 9-(cyclopropylmethyl)-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, bromide, [7(S)-(1α,2β,4β,5α,7β)]-
- 3-Oxa-9-azoniatricyclo[3.3.1.0<sup>2,4</sup>]nonane, 9-(cyclopropylmethyl)-7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9-methyl-, bromide (1:1), (1α,2β,4β,5α,7β)-
- 3-Oxa-9-azoniatricyclo[3.3.1.0<sup>2,4</sup>]nonane, 9-(cyclopropylmethyl)-7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9-methyl-, bromide, (1α,2β,4β,5α,7β)-
- 8-(Cyclopropylmethyl)-6beta,7beta-epoxy-3alpha-((S)-tropoyl)-1alphaH,5alphaH-tropanium bromid
- 8-(Cyclopropylmethyl)-6beta,7beta-epoxy-3alpha-hydroxy-1alphaH,5alphaH-tropanium bromide, (-)-(S)-tropate
- Alginor
- Ver más sinónimos
- Bromure de cimetropium
- Bromure de cimetropium [French]
- Bromuro de cimetropio
- Bromuro de cimetropio [Spanish]
- Cimetropii bromidum
- Cimetropii bromidum [Latin]
- Cimetropium bromide [INN]
- Da 3177
- N-Cyclopropylmethylscopolamine bromide
- Unii-0C7M5We60Q
Cimetropium bromide is a pharmacological agent that binds to muscarinic receptors, inhibiting the release of acetylcholine. It is used in the treatment of bowel disease, such as constipation and irritable bowel syndrome. Cimetropium bromide has been shown to be effective in treating symptoms of these diseases, including decreased intestinal motility, increased stool consistency, and relief from abdominal pain. Cimetropium bromide has also been found to be effective in reducing symptoms of inflammatory bowel disease. This drug inhibits the release of acetylcholine by binding with muscarinic receptors on the smooth muscle cells lining the intestine and bladder. Cimetropium bromide is a potent antimuscarinic agent that can cause dry mouth and blurred vision.
Propiedades químicas
Consulta técnica sobre: 3D-FC152009 Cimetropium bromide
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.